Medical News Today -
10 Oct 2013 11:00
Epigem, a hi-tech British company, has secured 716,000 Euros to play a leading role in the EU's CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project. Epigem's main role is to provide multifunctional microfluidic modules for blood sample preparation and multimodal measurements, design for prototyping and manufacturability based on application specifications using biocompatible materials which can be sterilised. The company will also...
Share this Article